BioTrove has developed two technology platforms that offer life science researchers techniques that provide greater analytical capacity and better quality data than traditional approaches.
OpenArray™ technology enables massively parallel, high quality nanoliter assays, such as qPCR. OpenArray™ technology is a broadly applicable nanoliter fluidics technology platform for massively parallel and low-volume solution-phase reactions including analysis of genetic, genomic, proteomic, biochemical, and cellular samples. Researchers using this technology benefit from the parallelism of microarrays and the data quality of solution-phase reactions, such as PCR. Read more.
RapidFire™ high throughput mass spectrometry enables label-free analysis of pharmaceutical compounds. BioTrove's high throughput mass spectrometry system consists of a proprietary computer-controlled fluidic robot, which is interfaced with a triple-quadrupole mass spectrometer. Sample throughput is decreased from minutes to seconds using RapidFire™ robotics, which replace conventional HPLC (high performance liquid chromatography) as the sample injection and purification system. Read more.
